PORTLAND, Oregon and PUNE, India, April 20, 2017 /PRNewswire/ --
According to a new report published by Allied Market Research, titled, "Multiplex Assays Market by Type, Product, Technology, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2014-2022," the global multiplex assays market was valued at $3,470 million in 2015, and is projected to reach $5,720 million by 2022, growing at a CAGR of 7.4% from 2016 to 2022. The protein-based multiplex assays segment held over two-thirds share of the total market in 2015.
Multiplex assays are techniques that analyze multiple analytes at the same time. Multiplex assays extract more data from a sample in less time as compared to single-plex assays. The key factors that drive the growth of the market include increase in research & development activities for the detection of biomarkers for various diseases & treatment options of the diseases; rise in adoption of personalized medicine for increasing safety & efficacy of therapies; benefits, such as lower operational cost & reduced labor; and technological advancements. However, shortage of skilled labor and high capital investment are expected to restrain the market growth during the forecast period.
Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-free-sample/1921
The multiplex assays market in this report is studied on the basis of type, product, technology, application, end user, and geography. Based on type, it is divided into nucleic acid-based multiplex assays, protein-based multiplex assays, and other multiplex assays. Protein-based multiplex assays held highest share over two-thirds in 2015, owing to high usage of multiplex assays for the differentiation of proteins on the basis of their properties in different fields, such as diagnostic clinics, research & development, and others.
By product the market is classified into multiplex assay consumables, multiplex assays instruments & accessories, and multiplex assay software & services. The multiplex assays reagents & consumable market held the highest share of three-fourths in 2015, and is expected to lead the market during the analysis period. Pharmaceuticals &biotechnological companies in end users held the highest market share of multiplex assays market in 2015, and are expected to show the highest growth rate during the analysis period, owing to the extensive use of multiplex assays in the R&D by pharmaceutical and biotechnology companies.
Check offers and discount on report @ https://www.alliedmarketresearch.com/get-discount/1921
Geographically, the global multiplex assays market is analyzed by four regions, namely, North America, Europe, Asia-Pacific, and LAMEA. North America was the highest revenue contributor with approximately half of the share in 2015, and is attributed to the ample amount of expenditure in healthcare, research & development, well-established healthcare system, and higher demand for technically advanced devices for research work. However, Asia-Pacific is anticipated to grow with the highest CAGR during the analysis period, owing to rise in healthcare expenditure, increase in per capita income & improved healthcare infrastructure.
KEY FINDINGS OF THE MULTIPLEX ASSAYS MARKET STUDY:
- The multiplex assays reagents & consumable market accounted for the highest market share for product segment in 2015, and is also estimated to grow at the highest CAGR of 7.7% in the analysis period.
- By application, research and development held the highest market share and expected to lead the market during the analysis period.
- U.S. was the highest shareholder in the North American multiplex assays market, accounting for six-sevenths share in 2015.
- China is expected to show the highest growth rate during the analysis period in the Asia-Pacific multiplex assays market.
According to Hemali Narkhede, Manager, Healthcare Research at Allied Market Research "Protein-based multiplex assays are expected to dominate global multiplex assays market during the forecast period, owing to their rise in adoption to analyze unknown proteins and their functions simultaneously and precisely."
Do Enquiry before purchasing Report @ https://www.alliedmarketresearch.com/purchase-enquiry/1921
The key players profiled in the global multiplex assays market are Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC., Seegene Inc., Meso Scale Diagnostics, LLC., and Randox Laboratories Ltd.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
SOURCE Allied Market Research